Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
about
Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, ChinaGenotypic analysis of Klebsiella pneumoniae isolates in a Beijing Hospital reveals high genetic diversity and clonal population structure of drug-resistant isolatesStructural diversity of class 1 integrons and their associated gene cassettes in Klebsiella pneumoniae isolates from a hospital in ChinaTreatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.Diagnosis of E. coli tricuspid valve endocarditis: a case report.A statistical approach for determination of disk diffusion-based cutoff values for systematic characterization of wild-type and non-wild-type bacterial populations in antimicrobial susceptibility testing.Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.Frequency, Antimicrobial Resistance and Genetic Diversity of Klebsiella pneumoniae in Food Samples.A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing EnterobacteriaceaeEvolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).Treatment of multidrug-resistant Gram-negative infections in children.The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications.The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations.Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.Necrotizing fasciitis and infective endocarditis caused by Escherichia coli in a hemodialysis patient.Native valve endocarditis due to extended spectrum β-lactamase producing Klebsiella pneumoniae.Contribution of fucose-containing capsules in Klebsiella pneumoniae to bacterial virulence in mice.Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860
Q28481714-F2989041-C5C0-4D78-A16D-30ACA575B621Q28486369-FCE688B6-2B6E-4288-9495-C45E9DCD5CEFQ28533900-A2132385-985C-45CB-B6D2-0131003B7AF6Q33826293-F4AD4649-2AC9-49BC-A809-C1C55A24B0AFQ34764281-47924F57-C4E4-4D8A-9AD8-2695B6A39EE1Q35607484-1688477C-0343-4C78-9944-891B90A41FF9Q35840852-CEC44334-C59E-4526-8571-E225A415ADD1Q35989920-3D0F90BE-8CA0-48D7-AD3B-67D3D99AE0E2Q37023191-BA3AF536-5B5F-49D5-8DB1-9F2ED3D70D03Q38074212-753B7820-4C6A-4B16-AF19-541EFEA5BB34Q38185648-53C6D214-DC96-439C-931B-E070AAD92C63Q38497797-0DFD3DC9-B42B-4B9B-B714-F10C3FF575FDQ38792841-56144890-DB71-421F-85DE-9867D2266BD3Q38864569-4F3817FB-8A40-45EF-B931-FC8DE5D2C440Q38934400-82761A73-D2DF-42DB-96A2-67B5BB5B4C26Q40672387-C465BBEB-DF57-4B39-BFCA-60E5C4F8A6B8Q41217004-BD02DDE1-ACDD-46A2-9B38-1A630474EF86Q41548382-31DC057E-6214-4FB3-A080-ECA480E8CF02Q42582349-9000C927-537E-4500-8872-397BFF35F5EAQ46835202-EB9841CF-9F6D-4A61-B114-1CB641479FFFQ47312597-0CDE6121-4998-4D1D-AB82-DE017805DD2FQ50523195-E0DB81E0-A488-47F1-AD4B-2C540D6DCE9BQ52695014-67F399E3-B306-4B13-A9E3-AFC652C464A7
P2860
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Endocarditis caused by extende ...... espite initial susceptibility.
@ast
Endocarditis caused by extende ...... espite initial susceptibility.
@en
type
label
Endocarditis caused by extende ...... espite initial susceptibility.
@ast
Endocarditis caused by extende ...... espite initial susceptibility.
@en
prefLabel
Endocarditis caused by extende ...... espite initial susceptibility.
@ast
Endocarditis caused by extende ...... espite initial susceptibility.
@en
P2093
P2860
P356
P1476
Endocarditis caused by extende ...... espite initial susceptibility.
@en
P2093
Inna Chmelnitsky
Oren Zimhony
Orly Hammer Muntz
Rita Bardenstein
Shiri Navon Venezia
Sorel Goland
Yehuda Carmeli
P2860
P304
P356
10.1128/AAC.00218-06
P407
P577
2006-09-01T00:00:00Z